Montes, RosaMollinedo, PilarPerales, SoniaGonzalez-Lamuño, DomingoRamos-Mejía, VeronicaFernandez-Luna, Jose LReal, Pedro J2023-01-252023-01-252019-04-22http://hdl.handle.net/10668/13890ADNP syndrome is an intellectual disability associated with Autism spectrum disorder caused by mutations in ADNP. We generated an iPSC line from an ADNP syndrome pediatric patient harboring the mutation p.Trp719* (GENYOi004-A). Peripheral blood mononuclear cells were reprogrammed using a non-transmissible form of Sendai viruses expressing the four Yamanaka factors (Oct3/4, SOX2, KLF4 and c-MYC). Characterization of GENYOi004-A included mutation analysis of ADNP by allele-specific PCR, genetic identity by Short Tandem Repeats polymorphism profiling, alkaline phosphatase enzymatic activity, expression of pluripotency-associated factors and pluripotency studies in vivo. GENYOi004-A will be useful to evaluate ADNP syndrome alterations at early developmental stages.enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/AnimalsAutism Spectrum DisorderCell DifferentiationCells, CulturedCellular ReprogrammingChildFemaleHomeodomain ProteinsHumansInduced Pluripotent Stem CellsKruppel-Like Factor 4Leukocytes, MononuclearMiceMice, Inbred NODMice, SCIDMutationNerve Tissue ProteinsPhenotypeTeratomaresearch article31035039open access10.1016/j.scr.2019.1014461876-7753https://doi.org/10.1016/j.scr.2019.101446